- Home
- TRAW vs AQMS Comparison
TRAW vs AQMS Comparison
Compare TRAW & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAW
- AQMS
- Stock Information
- Founded
- TRAW 1998
- AQMS 2014
- Country
- TRAW United States
- AQMS United States
- Employees
- TRAW N/A
- AQMS N/A
- Industry
- TRAW
- AQMS Metal Fabrications
- Sector
- TRAW
- AQMS Industrials
- Exchange
- TRAW NYSE
- AQMS Nasdaq
- Market Cap
- TRAW 7.8M
- AQMS 7.7M
- IPO Year
- TRAW 2013
- AQMS 2015
- Fundamental
- Price
- TRAW $1.40
- AQMS $0.52
- Analyst Decision
- TRAW
- AQMS Strong Buy
- Analyst Count
- TRAW 0
- AQMS 3
- Target Price
- TRAW N/A
- AQMS $21.00
- AVG Volume (30 Days)
- TRAW 3.4M
- AQMS 503.6K
- Earning Date
- TRAW 08-14-2025
- AQMS 08-04-2025
- Dividend Yield
- TRAW N/A
- AQMS N/A
- EPS Growth
- TRAW N/A
- AQMS N/A
- EPS
- TRAW N/A
- AQMS N/A
- Revenue
- TRAW $227,000.00
- AQMS N/A
- Revenue This Year
- TRAW $3.81
- AQMS N/A
- Revenue Next Year
- TRAW $30.43
- AQMS $550.00
- P/E Ratio
- TRAW N/A
- AQMS N/A
- Revenue Growth
- TRAW 0.44
- AQMS N/A
- 52 Week Low
- TRAW $0.97
- AQMS $0.51
- 52 Week High
- TRAW $19.44
- AQMS $7.92
- Technical
- Relative Strength Index (RSI)
- TRAW 42.63
- AQMS 25.92
- Support Level
- TRAW $1.62
- AQMS $0.53
- Resistance Level
- TRAW $1.77
- AQMS $0.83
- Average True Range (ATR)
- TRAW 0.15
- AQMS 0.11
- MACD
- TRAW -0.03
- AQMS -0.01
- Stochastic Oscillator
- TRAW 10.34
- AQMS 1.28
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.